Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin et al. · The Lancet Oncology · 2019 · Randomised trial
Full textCC BY